Status:
COMPLETED
Study of Patient Use and Perception of the Travatan Dosing Aid
Lead Sponsor:
Wills Eye
Collaborating Sponsors:
Alcon Research
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary objective of this study is to determine the opinions of patients who are given the Travatan Compliance Monitoring Dispenser to use to dispense their Travatan glaucoma drops.
Detailed Description
Patients enrolled in this study will use the new Travatan compliance monitoring dispenser for 6 weeks. Patients will be informed that some, but not all, patients' compliance will be monitored by the d...
Eligibility Criteria
Inclusion
- Open angle glaucoma or ocular hypertension
- Presently using Travatan eye drops
Exclusion
- Allergy to prostaglandin
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00626067
Start Date
September 1 2006
End Date
February 1 2007
Last Update
November 10 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.